Introducing Paratus — the BARDA Accelerator Network Hub for Digital Health. Click to learn more...

Stories

Stay up to date on all healthcare news from MATTER, Chicago's leading incubator and accelerator.

tales from the trenches

Tales from the Trenches with Frank Naeymi-Rad, Founder of Intelligent Medical Objects

June 13, 2019

Last month, Dr. Frank Naeymi-Rad, founder of Intelligent Medical Objects (IMO), joined us at MATTER to share the entrepreneurial story behind a revolutionary breakthrough in health IT.

Frank’s work has been monumental in helping to pioneer a standard approach to clinical language. His doctoral research became the foundation for some of the earliest electronic health record (EHR) systems — sold…

Read more

tales from the trenches

Tales from the Trenches with Paul Edick, CEO of Xeris Pharmaceuticals

May 9, 2019

In April, Paul Edick, CEO of Xeris Pharmaceuticals, joined us at MATTER to share insights and learnings from his remarkable entrepreneurial journey.

Xeris is the latest in Paul’s impressive track record leading biopharma startups like Durata Therapeutics (Nasdaq: DRTX), Ganic Pharmaceuticals and MedPointe Healthcare, Inc. Paul came out of retirement to take the helm at Xeris in 2017, and has…

Read more

tales from the trenches

Tales from the Trenches with Lisa Earnhardt, CEO of Intersect ENT

April 3, 2019

Last winter, Lisa Earnhardt joined us at MATTER to share her ten-year journey as CEO of Intersect ENT — one of only a handful of companies in the med tech space focused on ear, nose and throat care. Since 2008, Lisa has grown her team from 12 to more than 350 employees, orchestrated a successful IPO and guided the company through several product launches. Today, the company has a market cap of …

Read more

tales from the trenches

Digital health in the context of life: A conversation with David Van Sickle

November 15, 2018

Earlier this month, David Van Sickle joined us to share his journey as co-founder and CEO of Propeller Health, a digital health company that is bringing treatment for COPD and asthma into the 21st century.

David’s early career as a medical anthropologist led him to realize the need for better management of chronic respiratory disease — and how digitally powered therapy can step in to close the…

Read more

tales from the trenches

From academia to entrepreneurship: A conversation with Exicure CEO David Giljohann

October 25, 2018

Earlier this month, David Giljohann, CEO of immunotherapy company Exicure, shared his entrepreneurial story at Tales from the Trenches. David’s journey has taken him from graduate training in a university lab to the helm of Exicure, a Chicago-based biotechnology company that is pioneering the field of immunotherapy. In just seven years, David has taken Exicure public, raised more than $100 mill…

Read more